Browsing Tag
rare disease drugs
2 posts
The rare disease opportunity behind BridgeBio Pharma’s BBP-418 breakthrough (NASDAQ: BBIO)
BridgeBio Pharma advances BBP-418 after Phase 3 muscular dystrophy results. Could the therapy unlock a major rare disease opportunity? Read the full analysis.
Senores Pharmaceuticals (NSE: SENORES) launches Deferiprone Tablets in U.S. with Dr. Reddy’s Laboratories
Find out how Senores Pharmaceuticals Limited’s Deferiprone launch in the U.S. is reshaping its generics growth strategy. Read more for expert analysis!